Belle Mead, NJ, United States of America

Joseph Michael Kahn

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Novartis Ag. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph Michael Kahn. Retrieved from https://idiyas.com/inventor/joseph-michael-kahn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Joseph Michael Kahn: Innovator in Multiple Sclerosis Treatment

Introduction

Joseph Michael Kahn is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis. With a total of 4 patents, Kahn's work has the potential to impact many lives.

Latest Patents

Kahn's latest patents focus on innovative regimens and methods for treating multiple sclerosis using ofatumumab. The first patent discloses treatment regimens that utilize the administration of ofatumumab, an anti-CD20 monoclonal antibody, to patients during both a loading dose regimen and a maintenance regimen. This approach aims to enhance the effectiveness of treatment for individuals suffering from multiple sclerosis.

Career Highlights

Joseph Michael Kahn is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field, further advancing research and treatment options for multiple sclerosis.

Collaborations

Kahn has worked alongside notable colleagues such as Marina Savelieva Praz and Algirdas Jonas Kakarieka Weisskopf. Their combined expertise contributes to the innovative solutions being developed in the realm of multiple sclerosis treatment.

Conclusion

Joseph Michael Kahn's contributions to the field of medicine, particularly in the treatment of multiple sclerosis, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to improving patient outcomes through innovative therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…